Urticarial Dermatitis: Clinical Characteristics of Itch and Therapeutic Response to Cyclosporine
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Urticarial dermatitis, which is characterised by persistent wheals with eczematous papules and plaques, is frequently misdiagnosed and difficult to treat. Patients commonly experience intolerable pruritus which may greatly affect their quality of life. Objective: The objective of this study is to characterize the clinical patterns of pruritus in patients with urticarial dermatitis and to determine the effectiveness of cyclosporine treatment. Methods: This prospective study included 50 histopathologically confirmed patients with urticarial dermatitis. A face-to-face structured questionnaire was given to all patients, and they were treated with low-dose cyclosporine (1∼3 mg/kg/d) for at least 2 weeks. Results: The majority of patients (80.0%) had moderate to severe pruritus. Most patients experienced exacerbation of the itch in the evening (74.0%), with the extremities (upper, 86.0%; lower, 94.0%) being the most commonly involved sites. Due to severe pruritus, patients complained about reduced social contact, quality of life and difficulties in falling asleep et al. Cyclosporine significantly reduced the mean itch score and extent of erythema, and improved interference with daily activities and sleep. Conclusion: Our study highlights the detailed description and characteristics of pruritus in patients with urticarial dermatitis. And we recommend alternative and effective therapeutic option of low-dose cyclosporine.
Abstract
Background: Urticarial dermatitis, which is characterised by persistent wheals with eczematous papules and plaques, is frequently misdiagnosed and difficult to treat. Patients commonly experience intolerable pruritus which may greatly affect their quality of life. Objective: The objective of this study is to characterize the clinical patterns of pruritus in patients with urticarial dermatitis and to determine the effectiveness of cyclosporine treatment. Methods: This prospective study included 50 histopathologically confirmed patients with urticarial dermatitis. A face-to-face structured questionnaire was given to all patients, and they were treated with low-dose cyclosporine (1∼3 mg/kg/d) for at least 2 weeks. Results: The majority of patients (80.0%) had moderate to severe pruritus. Most patients experienced exacerbation of the itch in the evening (74.0%), with the extremities (upper, 86.0%; lower, 94.0%) being the most commonly involved sites. Due to severe pruritus, patients complained about reduced social contact, quality of life and difficulties in falling asleep et al. Cyclosporine significantly reduced the mean itch score and extent of erythema, and improved interference with daily activities and sleep. Conclusion: Our study highlights the detailed description and characteristics of pruritus in patients with urticarial dermatitis. And we recommend alternative and effective therapeutic option of low-dose cyclosporine.
참고문헌 (11)
- Hannon GR, "Urticarial dermatitis:clinical features, diagnostic evaluation, and etiologic associations in a series of 146 patients at Mayo Clinic (2006∼2012)", J Am Acad Dermatol, 70, pp.263~268 (2014)
- Kossard S, "Defining urticarial dermatitis:a subset of dermal hypersensitivity reaction pattern", Arch Dermatol, 142, pp.29~34 (2006)
- Lee JS, "Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis", J Am Acad Dermatol, 56, pp.994~1005 (2007)
- Peroni A, "Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part II. Systemic diseases", J Am Acad Dermatol, 62, pp.557~570 (2010)
- Kazmierowski JA, "Dermatologic manifestations of the hypereosinophilic syndrome", Arch Dermatol, 114, pp.531~535 (1978)
- Irem Eren Erturk, "Effect of the Pruritus on the Quality of Life: A Preliminary Study", Annals of Dermatology, 24(4), pp.406~412 (2012), 대한피부과학회
- Patel T, "Nocturnal itch: why do we itch at night?", Acta Derm Venereol, 87, pp.295~298 (2007)
- Haest C, "Measurement of itching: validation of the Leuven Itch Scale", Burns, 37, pp.939~950 (2011)
- Chaptini C, "Mycophenolate mofetil as a treatment for urticarial dermatitis", Australas J Dermatol, 55, pp.275~278 (2014)
- Asero R, "Oral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing", Clin Exp Dermatol, 30, pp.582~583 (2005)
- Tedeschi A, "Chronic urticaria:a role for newer immunomodulatory drugs?", Am J Clin Dermatol, 4, pp.297~305 (2003)